VG
Insider
Vivek Garipalli
DirectorVivek Garipalli (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Clover Health Investments, Corp. (CLOV). Across 1 priced purchase filing, the average 21-session return was +20.1% from execution and +24.0% from disclosure (delay-adjusted; derived). The largest single filing was $930K of CLOV (415,000 sh × $2.24, as filed), executed Aug 7 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+20.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+24.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$930K
shares × price, as filed
Last traded
Aug 7 2025
Filed Aug 8 2025
Median ADV $28.6M across their filed names
Open performance→Volume by month
Buys $930K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CLOVRecent filings
CLOVPURCHASE
Clover Health Investments, Corp.
View filing →
$930K415,000 sh × $2.24
Exec Aug 7 2025
Filed Aug 8 2025 · 4:07 PM ET